Canaloplasty Voxpop with Dr. Robert Noecker (USA) скачать в хорошем качестве

Canaloplasty Voxpop with Dr. Robert Noecker (USA)

With undergraduate studies in engineering from MIT, Robert Noecker, MD, knows a well engineered device when he sees one. In this Vox Pop he explains how the iTrack™ Advance system streamlines the canaloplasty procedure for safe and effective glaucoma treatment. From intuitive visualization to tissue-sparing IOP control, it’s all about restoring flow without sacrificing future treatment options. The iTrack™ Advance has a US Food and Drug Administration (FDA) 510(k) and CE Mark (Conformité Européenne) for the treatment of open-angle glaucoma. Indications for Use, USA: The iTrack™ Advance is indicated for fluid infusion or aspiration during surgery. The iTrack™ Advance is indicated for the cutting or disruption of the trabecular meshwork during goniotomy procedures.* The iTrack™ Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma. The ab interno surgical technique is not a cleared indication for the iTrack™ Advance in the USA. The iTrack™ Advance cutting function (goniotomy) is a Class 1 510(k) exempt device function that is not specifically indicated for the reduction of intraocular pressure (IOP) or the treatment of open-angle glaucoma. Indications for Use, International: The iTrack™ Advance is indicated for fluid infusion or aspiration during surgery. The iTrack™ Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma. For more information in relation to approved labelling and indications for use, please visit https://itrack-advance.com.